A phase IV, randomized, double-blind cross-over study comparing the clinical safety, efficacy and duration of abobotulinumtoxinA with onabotulinumtoxinA in adults with upper-limb spasticity: The DIRECTION study

被引：0
|
作者：
Esquenazi, A.
Ayyoub, Z.
Verduzco-Gutierrez, M.
Maisonobe, P.
Otto, J.
Patel, A.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
72
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol
    Esquenazi, Alberto
    Ayyoub, Ziyad
    Verduzco-Gutierrez, Monica
    Maisonobe, Pascal
    Otto, James
    Patel, Atul T.
    ADVANCES IN THERAPY, 2021, 38 (11) : 5623 - 5633
  • [2] AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol
    Alberto Esquenazi
    Ziyad Ayyoub
    Monica Verduzco-Gutierrez
    Pascal Maisonobe
    James Otto
    Atul T. Patel
    Advances in Therapy, 2021, 38 : 5623 - 5633
  • [3] ABOBOTULINUMTOXINA (DYSPORT®): DOSES USED TO TREAT UPPER LIMB MUSCLES OF ADULTS WITH SPASTICITY PARTICIPATING IN A PHASE III RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    McAllister, Peter
    Walker, Heather
    Marciniak, Christina
    Edgley, Steven
    Gul, Fatuma
    Rubin, Bruce
    Simpson, David
    Picaut, Philippe
    MUSCLE & NERVE, 2016, 54 (03) : 631 - 631
  • [4] Extension Study to Assess the Safety and Efficacy of Repeated AbobotulinumtoxinA Injections in Adults with Upper Limb Spasticity
    Brashear, Allison
    Marciniak, Christina
    Edgley, Steven
    Gul, Fatma
    Hedera, Peter
    McAllister, Peter
    O'Dell, Michael
    Rubin, Bruce
    Walker, Heather
    Vilain, Claire
    Mahmood, Adnan
    Gracies, Jean-Michel
    NEUROLOGY, 2016, 86
  • [5] Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial
    Gracies, Jean-Michel
    Brashear, Allison
    Jech, Robert
    McAllister, Peter
    Banach, Marta
    Valkovic, Peter
    Walker, Heather
    Marciniak, Christina
    Deltombe, Thierry
    Skoromets, Alexander
    Khatkova, Svetlana
    Edgley, Steven
    Gul, Fatma
    Catus, France
    De Fer, Beatrice Bois
    Vilain, Claire
    Picaut, Philippe
    LANCET NEUROLOGY, 2015, 14 (10): : 992 - 1001
  • [6] Randomized, double-blind cross-over study of levothyroxine bioavailability
    Krehan, A
    Dittmar, M
    Hoppen, A
    Lichtwald, K
    Kahaly, GJ
    MEDIZINISCHE KLINIK, 2002, 97 (09) : 522 - 527
  • [7] Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study
    Rappl, Thomas
    Parvizi, Daryousch
    Friedl, Herwig
    Wiedner, Maria
    May, Simone
    Kranzelbinder, Bettina
    Wurzer, Paul
    Hellbom, Bengt
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2013, 6 : 211 - 219
  • [8] A DOUBLE-BLIND CROSS-OVER STUDY COMPARING THE ANALGESIC EFFICACY OF TRAMADOL WITH PENTAZOCINE IN PATIENTS WITH OSTEOARTHRITIS
    BIRD, HA
    HILL, J
    STRATFORD, ME
    FENN, GC
    WRIGHT, V
    JOURNAL OF DRUG DEVELOPMENT AND CLINICAL PRACTICE, 1995, 7 (03): : 181 - 188
  • [9] Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study
    Delgado, Mauricio R.
    Tilton, Ann
    Carranza-Del Rio, Jorge
    Dursun, Nigar
    Bonikowski, Marcin
    Aydin, Resa
    Maciag-Tymecka, Iwona
    Oleszek, Joyce
    Dabrowski, Edward
    Grandoulier, Anne-Sophie
    Picaut, Philippe
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2021, 63 (05): : 592 - U14
  • [10] A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke
    Bakheit, AMO
    Pittock, S
    Moore, AP
    Wurker, M
    Otto, S
    Erbguth, F
    Coxon, L
    EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (06) : 559 - 565
12345